Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Malignant sex cord stromal tumor (SCST) of ovary is a rare ovarian cancer arising from granulosa, theca, sertoli and leydig cells or stromal fibroblasts, occurring at any age and presenting with abdominal or pelvic mass, and characterized (with the exception of fibroma) by the production of sex steroids resulting in manifestations of hormone excess, with a relatively favorable prognosis.
Biomarker and diagnostic research for malignant sex cord stromal tumor of ovary has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for malignant sex cord stromal tumor of ovary.
128 publications have been identified in PubMed for malignant sex cord stromal tumor of ovary. Kisho has analyzed 88 by research type. Research spans Case Report / Case Series (28%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 25 | 28% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:51 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
18 |
20% |
Testing and diagnosis research | 15 | 17% |
Disease patterns and progression | 12 | 14% |
Laboratory research | 11 | 13% |
Clinical study results | 5 | 6% |
New treatment approaches | 2 | 2% |
Bach Chair U (2026). [PMID: 41199453](https://pubmed.ncbi.nlm.nih.gov/41199453/). *Toxicol Pathol*. [Review / Meta-Analysis]
Lucas E (2026). [PMID: 41021597](https://pubmed.ncbi.nlm.nih.gov/41021597/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Li H (2026). [PMID: 41957320](https://pubmed.ncbi.nlm.nih.gov/41957320/). *Virchows Arch*. [Basic Science / Preclinical]
Grisham RN (2026). [PMID: 41518037](https://pubmed.ncbi.nlm.nih.gov/41518037/). *Clinical and translational medicine*. [Clinical Trial Publication]
Due LP (2026). [PMID: 41690204](https://pubmed.ncbi.nlm.nih.gov/41690204/). *Gynecol Oncol*. [Case Report / Case Series]
Dwyer E (2026). [PMID: 41605125](https://pubmed.ncbi.nlm.nih.gov/41605125/). *Gynecol Oncol*. [Clinical Trial Publication]
Mitra S (2026). [PMID: 41161696](https://pubmed.ncbi.nlm.nih.gov/41161696/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Li HC (2026). [PMID: 42036198](https://pubmed.ncbi.nlm.nih.gov/42036198/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]
Gupta A (2026). [PMID: 40991421](https://pubmed.ncbi.nlm.nih.gov/40991421/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Schneider DT (2025). [PMID: 40272823](https://pubmed.ncbi.nlm.nih.gov/40272823/). *Cancer*. [Epidemiology / Natural History]